Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
3(14%)
Results Posted
25%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph early_phase_1
1
5%
Ph not_applicable
1
5%
Ph phase_1
3
14%
Ph phase_3
9
43%
Ph phase_4
7
33%

Phase Distribution

4

Early Stage

0

Mid Stage

16

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
1(4.8%)
Phase 1Safety & dosage
3(14.3%)
Phase 3Large-scale testing
9(42.9%)
Phase 4Post-market surveillance
7(33.3%)
N/ANon-phased studies
1(4.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

21

all time

Status Distribution
Active(4)
Completed(12)
Terminated(1)
Other(4)

Detailed Status

Completed12
unknown4
Recruiting3
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
3
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.8%)
Phase 13 (14.3%)
Phase 39 (42.9%)
Phase 47 (33.3%)
N/A1 (4.8%)

Trials by Status

completed1257%
unknown419%
enrolling_by_invitation15%
recruiting314%
terminated15%

Recent Activity

3 active trials
Showing 5 of 21
recruitingphase_3

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

NCT06358313
recruitingphase_3

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

NCT06360120
completedphase_4

Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

NCT03988101
recruitingphase_4

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

NCT04499859
enrolling_by_invitationphase_4

Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention

NCT06820086
View all 21 trials

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT06358313Phase 3

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

Recruiting
NCT06360120Phase 3

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

Recruiting
NCT03988101Phase 4

Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

Completed
NCT04499859Phase 4

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

Recruiting
NCT06820086Phase 4

Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention

Enrolling By Invitation
NCT06105060Early Phase 1

Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis

Completed
NCT05338723Phase 3

Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients

Completed
NCT03889314Phase 4

The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial

Unknown
NCT04895059Phase 1

Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

Completed
NCT04776889Phase 4

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Completed
NCT02968160Phase 4

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

Terminated
NCT02434497Phase 3

A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Completed
NCT02770261Phase 3

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

Completed
NCT02127320Phase 1

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

Completed
NCT02859480Phase 4

Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI

Unknown
NCT02305862Not Applicable

A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques

Unknown
NCT02226198Phase 3

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Completed
NCT02445352Phase 3

Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia

Completed
NCT01918332Phase 3

Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia

Completed
NCT02087540Phase 3

Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
21